aid: covance
name: Covance (Fortrea)
kind: company
description: >-
  Covance was a contract research organization (CRO) acquired by Labcorp in 2015
  and rebranded as Labcorp Drug Development in 2021. In 2023, the clinical
  development business was spun off as Fortrea, an independent CRO headquartered
  in Durham, North Carolina, operating in 90+ countries and serving the
  pharmaceutical, biotechnology, and medical device industries with clinical
  trial management, central laboratory, and bioanalytical services. No public
  API or developer portal is currently published; integrations are arranged
  through sponsor and partner agreements.
image: https://kinlane-productions2.s3.amazonaws.com/apis-json/apis-json-logo.jpg
url: https://raw.githubusercontent.com/api-evangelist/covance/refs/heads/main/apis.yml
type: Index
access: 3rd-Party
position: Consuming
created: '2024-01-01'
modified: '2026-04-28'
tags:
  - Bioanalytical
  - Biotechnology
  - Central Laboratory
  - Clinical Development
  - Clinical Trials
  - Contract Research Organization
  - CRO
  - Drug Development
  - Pharmaceutical
apis: []
common:
  - type: Website
    url: https://www.fortrea.com
  - type: LegacyWebsite
    url: https://www.covance.com
  - type: LabcorpDrugDevelopment
    url: https://drugdevelopment.labcorp.com/
  - type: About
    url: https://www.fortrea.com/about-us
  - type: ClinicalDevelopment
    url: https://www.fortrea.com/services
  - type: ContactSales
    url: https://www.fortrea.com/contact-us
  - type: LinkedInFortrea
    url: https://www.linkedin.com/company/fortrea/
  - type: LinkedInCovance
    url: https://www.linkedin.com/company/covancedrugdevelopment
  - type: PrivacyPolicy
    url: https://www.fortrea.com/privacy-policy
  - type: TermsOfUse
    url: https://www.fortrea.com/terms-of-use
maintainers:
  - FN: Kin Lane
    email: kin@apievangelist.com